Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Pituitary Disorders
•
General Endocrinology
When do you recommend using L-arginine stimulated copeptin testing to evaluate for central diabetes insipidus (AVP-deficiency)?
Related Questions
How do you approach a patient with Paget’s disease of bone with elevated alkaline phosphatase and history of chronic kidney disease?
How do 24-hour urine creatinine levels affect your interpretation of 24-hour urinary calcium or cortisol studies?
Should we be considering transsphenoidal surgical resection as first-line therapy for prolactinomas?
Can the desmopressin stimulation test be used to assess for central adrenal insufficiency?
Should men with familial PCOS be screened earlier for cardiometabolic disease?
Do you pursue additional cardiac evaluation for patients diagnosed with Sheehan Syndrome, considering their elevated risk for atherosclerotic cardiovascular diseases?
How often do you monitor pituitary adenomas once established as non-functioning?
Do you interpret failure to develop hypernatremia with prolonged water deprivation (such as for 12 hours) as evidence against diabetes insipidus even if the urine osmolality is just below normal?
Would you evaluate for an ectopic source in a patient with persistently elevated IGF-1 level but no clinical features of acromegaly or evidence of pituitary abnormalities?
Is there a role for the use of SGLT2 inhibitors for the treatment of reactive hypoglycemia not responsive to dietary modifications or acarbose?
